DELIZICOL

Mesalamine is a generic medication that is prescribed to individuals with ulcerative colitis, a bowel disease. Its purpose is to alleviate symptoms associated with ulcerative colitis, including diarrhea, rectal bleeding, and stomach pain.

Search savings options using NowPatient. If you are a commercially insured patient, you may be eligible to pay only $10 per monthly prescription with the Delzicol Savings Card. This offer is valid for up to 12 prescriptions and can save you a maximum of $4080 per calendar year. For more information, please contact the program at 855-706-8716.

Delzicol (mesalamine) – There is a lower-cost generic available.
Mesalamine – There is a lower-cost generic available.
Entyvio (vedolizumab) – There is no lower-cost generic available.

Delzicol (mesalamine) is classified as an aminosalicylate drug and is utilized for the treatment of gut inflammation. It effectively manages and prevents flare-ups associated with ulcerative colitis, an inflammatory bowel disease (IBD).

The typical adverse reactions experienced with DELZICOL in adults consist of belching, stomachache, constipation, dizziness, runny nose, back pain, rash, upset stomach, and flu-like symptoms.

This medication effectively targets inflammation and alleviates various symptoms of the disease. It can only be obtained with a prescription from your doctor.

Delzicol, an FDA-approved prescription medication, is used to treat mild to moderate cases of ulcerative colitis in individuals aged five and above. Additionally, it is prescribed to adults for the purpose of maintaining remission.

Possible side effects of this medication include stomach upset, nausea/vomiting, constipation, headache, or joint/muscle pain. If any of these symptoms persist or worsen, it is important to inform your doctor or pharmacist immediately. Additionally, it is possible to occasionally notice whole or partial tablets/capsules in your stool. If this happens frequently, it is recommended to consult your doctor.

After receiving approval and being widely used, there have been occasional reports of mesalamine therapy causing acute and chronic liver injury with jaundice. It is estimated that clinically noticeable liver injury occurs in approximately 3.2 cases per million prescriptions.

Delzicol is a delayed-release capsule that comes in a 400 mg strength. To treat mildly to moderately active ulcerative colitis, patients should take 800 mg of Delzicol three times a day.

Each capsule of DELZICOL (mesalamine) contains four 100 mg tablets of mesalamine, which is an aminosalicylate. These capsules are designed to be taken orally and are delayed-release.

Mesalazine, classified as an aminosalicylate, is prescribed for the treatment of ulcerative colitis, Crohn’s disease, and other forms of inflammatory bowel disease. Its primary function is to alleviate inflammation and swelling, ultimately aiding in the healing process.

Mesalamine should be used with caution if you have certain medical conditions, such as an allergy to aspirin or sulfasalazine, heart, liver, or kidney disease, or a blockage in your stomach or intestines.

You should take Mesalamine orally with a glass of water as prescribed. It is available in extended-release capsules or tablets under the brand names Asacol, Delzicol, Lialda, and Pentasa.

Allergan Pharmaceuticals International Ltd. sent a letter to the FDA on May 13, 2022, informing them of their decision to discontinue ASACOL HD (Mesalamine) Delayed-Release Tablet, 800 mg. As a result, the FDA has transferred the drug product to the “Discontinued Drug Product List” section of the Orange Book.

If you experience lower back or side pain, decreased urine frequency or amount, bloody urine, increased thirst, loss of appetite, nausea, vomiting, unusual tiredness or weakness, swelling of the face, fingers, or lower legs, weight gain, or difficulty breathing, it is important to consult your doctor immediately.

You inform your patient that there are several potential benefits of using mesalamine continuously and for a long period of time, although the available data supporting these benefits are limited. Studies indicate that regular use of mesalamine increases the likelihood of achieving remission for symptom control, on average.

Mesalamine, which is the generic version of Delzicol, functions by decreasing inflammation in the colon. While the average retail price of Delzicol is typically $852.24, you have the option to obtain the generic Delzicol for only $150.88 through NowPatient Rx Advantage Card.

The primary medications for treating ulcerative colitis are Balsalazide, Mesalamine, Olsalazine, and Sulfasalazine. These medications are available in both pill and suppository forms. If you have a sulfa allergy, it is important to inform your doctor before starting any of these medications. In such cases, your doctor can prescribe a sulfa-free 5-ASA medication.

Mesalamine is a medication that requires a prescription and is used to induce remission in patients with active, mild to moderate ulcerative colitis, as well as to maintain remission of ulcerative colitis. It is sold under various brand names, including Asacol HD, Pentasa, Delzicol, Lialda, and Apriso.

There are multiple oral 5-ASA agents that are based on mesalamine, such as Asacol HD, Pentasa, Lialda, Apriso, and Delzicol. While these agents all contain the same mesalamine, they vary in terms of their medication coating. The purpose of coating or encapsulating mesalamine is to ensure that the drug is delivered to the intestine or colon effectively.

Furthermore, Lialda has the potential to induce kidney complications or harm as an adverse effect. If you already have kidney issues, you may be at a greater risk. It is advisable to consult your doctor to assess the safety of taking Lialda in conjunction with your kidney problems. Additionally, liver problems should also be taken into consideration.

There are no specific food or drink restrictions while taking or using mesalazine. However, if you experience indigestion or nausea, it is recommended to consume simple meals and avoid alcohol and spicy foods.

Mesalamine is the active drug found in the brand-name medication Lialda, which is also available in generic forms. Generic drugs are identical copies of the active drug in a brand-name medication and are considered to be just as safe and effective.

Lialda (mesalamine) and Entyvio (vedolizumab) are available in different dosage forms. Lialda is available as an oral delayed release tablet, while Entyvio is available as an intravenous powder for injection. Other brands of mesalamine include Apriso, Asacol, Asacol HD, Canasa, Canasa Pac, Delzicol, Pentasa, Rowasa, Rowasa Sulfite Free, and Zaldyon.

Lialda is the brand name for mesalamine, which is only available with a prescription and does not have a generic form.

Please keep in mind that your doctor has prescribed this medication because they believe that the benefits outweigh the potential risks of side effects. It is important to note that most individuals who use this medication do not experience any serious side effects. However, in rare cases, mesalamine may potentially exacerbate ulcerative colitis.

Lialda works by targeting a specific substance in the body that leads to inflammation, tissue damage, and diarrhea. It is prescribed for the treatment of mild to moderate active ulcerative colitis in both adults and children weighing at least 24kg.

Nevertheless, if not detected, extended exposure to the medication can result in irreversible kidney failure and end-stage kidney disease.

If you experience lower back or side pain, decreased urine frequency or amount, bloody urine, increased thirst, loss of appetite, nausea, vomiting, unusual tiredness or weakness, swelling of the face, fingers, or lower legs, weight gain, or difficulty breathing, it is important to consult your doctor immediately.

Based on our findings, it can be concluded that the long-term risk of flare in patients starting mesalamine is not affected by the average daily dose, as long as the patients maintain a high to moderate level of adherence.

Possible side effects of this medication include stomach upset, nausea, vomiting, constipation, headache, and joint or muscle pain. If any of these symptoms persist or worsen, it is important to notify your doctor or pharmacist immediately. Additionally, it is possible to occasionally observe whole or partial tablets or capsules in your stool.

Some of the common side effects of this medication include headache, muscle or joint pain, back pain, nausea, vomiting, heartburn, constipation, gas, dry mouth, sore throat, cough, flu-like symptoms, stuffy head or runny nose, ear pain, anxiety, sweating, acne, slight hair loss, and diarrhea.

Delzicol is supplied in the form of 400 mg DR capsules, which consist of four 100 mg tablets enclosed within. However, it is important to note that Delzicol should not be substituted or used interchangeably with Asacol HD.

Allergan Pharmaceuticals International Ltd. sent a letter to the FDA on May 13, 2022, informing them of their decision to discontinue ASACOL HD (Mesalamine) Delayed-Release Tablet, 800 mg. As a result, the FDA has transferred the drug product to the “Discontinued Drug Product List” section of the Orange Book.

If you have any doubts about purchasing medication online, especially mesalamine capsules, delayed release, it is recommended to consult your healthcare provider for guidance. Additionally, you can refer to the Generic Drug FAQ for more information.

Asacol HD (mesalamine): There is a lower-cost generic available. For more information about Asacol HD (mesalamine), click here.

Entyvio (vedolizumab): There is no lower-cost generic available. For more information about Entyvio (vedolizumab), click here.

Pentasa (mesalamine): There is a lower-cost generic available. For more information about Pentasa (mesalamine), click here.

In the treatment of acute ulcerative colitis, balsalazide is proven to be more effective and better tolerated compared to mesalamine.

Mesalamine is a medication that requires a prescription and is used to induce remission in patients with active, mild to moderate ulcerative colitis, as well as to maintain remission of ulcerative colitis. It is sold under various brand names, including Asacol HD, Pentasa, Delzicol, Lialda, and Apriso.

Asacol (mesalamine) is a medication that reduces inflammation and is prescribed for the treatment of ulcerative colitis, proctitis, and proctosigmoiditis. It is also used to prevent the recurrence of symptoms associated with ulcerative colitis.